Previously recorded as Home Dialysis Plus, Ltd. (to 2015)
22 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Jun 2027
Next term end
10
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2033 · High confidence
Also notable
Ends Jul 2031 · High confidence
Also notable
Ends Apr 2035 · High confidence
Also notable
Ends Jun 2027 · High confidence
Also notable
Ends Oct 2028 · High confidence
Also notable
Ends Dec 2039 · High confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Dec 2041 · High confidence
Dialysis System
US 8,801,922
The most cited patent in this portfolio, cited by 166 later US patents, top 5% of utility patents granted in 2014 in our data. Protection runs to 2033.
Dialysis System with Ultrafiltration Control
US 8,753,515
Cited by 157 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Dialysis System and Methods
US 11,305,040
Cited by 7 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2035.
Mecs Diayzer
US 8,128,822
Cited by 65 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Microfluidic Devices, Particularly Filtration Devices Comprising Polymeric Membranes, and Method for Their Manufacture and Use
US 7,955,504
Cited by 60 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Peritoneal Dialysis System and Methods
US 11,534,537
Cited by 6 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2039.
Heat Exchange Fluid Purification for Dialysis System
US 9,328,969
Cited by 21 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Dialysis System and Methods
US 12,201,762
Granted 2025. Too new for citation comparison; protection runs to 2041.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 15, 2027The maintenance fee for Fluid Purification System (US 11,724,013) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 1 fee due Mar 22, 2027The maintenance fee for Fluid Purification System (US 9,138,687) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due Oct 9, 2027The maintenance fee for Peritoneal Dialysis System and Methods (US 11,951,241) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Heat Exchange Fluid Purification for Dialysis System (US 9,328,969) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
What they patent
The largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Dialysis System | 7 in force | to May 2033 |
| Dialysis System and Methods (2015) | 4 in force | to Apr 2035 |
| Peritoneal Dialysis System and Methods | 3 in force | to Dec 2039 |
| Dialysis System with Ultrafiltration Control | 2 in force | to Jul 2031 |
| Dialysis System Having Remote Monitoring and Control | 1 in force | to Aug 2043 |
| Dialysis Systems and Methods | 1 in force | to Apr 2042 |
| Dialysis System and Methods (2019) | 1 in force | to Dec 2041 |
| Microfluidic Devices, Particularly Filtration Devices Comprising Polymeric Membranes, and Method for Their Manufacture and Use | 1 in force | to Oct 2028 |
| Mecs Diayzer | 1 in force | to Jun 2027 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,128,822 | Mecs Diayzer In force · High confidence | In force | High confidence | |
| US 7,955,504 | Microfluidic Devices, Particularly Filtration Devices Comprising Polymeric Membranes, and Method for Their Manufacture and Use In force · High confidence | In force | High confidence | |
| US 9,138,687 | Fluid Purification System In force · High confidence | In force | High confidence | |
| US 9,545,469 | Dialysis System with Ultrafiltration Control In force · High confidence | In force | High confidence | |
| US 10,105,476 | Fluid Purification System In force · High confidence | In force | High confidence | |
| US 11,724,013 | Fluid Purification System In force · Medium confidence | In force | Medium confidence | |
| US 10,668,201 | Dialysis System In force · Medium confidence | In force | Medium confidence | |
| US 8,753,515 | Dialysis System with Ultrafiltration Control In force · High confidence | In force | High confidence | |
| US 8,685,251 | Ultra-Pasteurization for Dialysis Machines In force · High confidence | In force | High confidence | |
| US 9,895,480 | Dialysis System In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 22: 5 patents ended · 7 applications pending · 15 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.